Abstract
The catechol-O-methyltransferase gene (COMT) plays a crucial role in the metabolism of catecholamines in the frontal cortex. A single nucleotide polymorphism (Val158Met SNP, rs4680) leads to either methionine (Met) or valine (Val) at codon 158, resulting in a three- to fourfold reduction in COMT activity. The aim of the present study was to assess the COMT Val158Met SNP as a risk factor for attention-deficit/hyperactivity disorder (ADHD), ADHD symptom severity and co-morbid conduct disorder (CD) in 166 children with ADHD. The main finding of the present study is that the Met allele of the COMT Val158Met SNP was associated with ADHD and increased ADHD symptom severity. No association with co-morbid CD was observed. In addition, ADHD symptom severity and early adverse familial environment were positive predictors of lifetime CD. These findings support previous results implicating COMT in ADHD symptom severity and early adverse familial environment as risk factors for co-morbid CD, emphasizing the need for early intervention to prevent aggressive and maladaptive behavior progressing into CD, reducing the overall severity of the disease burden in children with ADHD.
Similar content being viewed by others
References
Adams C, Broide R, Chen Y, Winzer-Serhan U, Henderson T, Leslie F et al (2002) Development of the alpha7 nicotinic cholinergic receptor in rat hippocampal formation. Brain Res Dev Brain Res 139:175–187
Antshel KM, Fremont W, Roizen NJ, Shprintzen R, Higgins AM, Dhamoon A et al (2006) ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome. J Am Acad Child Adolesc Psychiatry 45:596–603
APA (1994). Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington DC
Arnsten A, Li B (2005) Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57:1377–1384
Baler R, Volkow N, Fowler J, Benveniste H (2008) Is fetal brain monoamine oxidase inhibition the missing link between maternal smoking and conduct disorders. J Psychiatry Neurosci 33(3):187–195
Barr CL, Wigg K, Malone M, Schachar R, Tannock R, Roberts W et al (1999) Linkage study of catechol-O-methyltransferase and attention-deficit hyperactivity disorder. Am J Med Genet 88:710–713
Bennett A, Lesch K, Heils A, Long J, Lorenz J, Shoaf S et al (2002) Early experience and serotonin transporter gene variation interact to influence primate CNS function. Mol Psychiatry 7:118–122
Bhutta A, Cleves M, Casey P, Cradock M, Anand K (2002) Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. JAMA 288(6):728–737
Biederman J, Monuteaux M, Seidman L et al (2004) Impact of executive function deficits and ADHD on academic outcomes in children. J Consult Clin Psychol 72:757–766
Bremner J, Vermetten E (2001) Stress and development: behavioral and biological consequences. Dev Psychopathol 13(3):473–489
Cairns N, Wonnacott S (1988) [3H](-)nicotine binding sites in fetal human brain. Brain Res 475:1–7
Cheuk D, Wong V (2006) Meta-analysis of association between a catechol-O-methyltransferase gene polymorphism and attention deficit hyperactivity disorder. Behav Genet 36:651–659
Chomitz V, Cheung LWY, Lieberman E (1995) The role of lifestyle in preventing low birth weight. Future Child 5(1):121–138
Connor D, Edwards G, Fletcher K, Baird J, Barkley R, Steingard R (2003) Correlates of Comorbid Psychopathology in Children with ADHD. J Am Acad Child Adolesc Psychiatry 42:193–200
Dani J, Bertrand D (2006) Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol
Döpfner M, Lehmkuhl G (1998) Diagnostik-System für psychische Störungen im Kindes- und Jugendalter nach ICD-10 und DSM-IV (DISYPS-KJ). Hans Huber, Berne
Doyle A (2006) Executive functions in attention-deficit/hyperactivity disorder. J Clin Psychiatry 67(Suppl 8):21–26
Dudbridge F (2008) Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66:87–98
Eisenberg J, Mei-Tal G, Steinberg A, Tartakovsky E, Zohar A, Gritsenko I et al (1999) Haplotype relative risk study of Catechol-O-Methyltransferase (COMT) and Attention Deficit Hyperactivity Disorder (ADHD). Am J Med Gen 55(5):497–502
Ernst M, Moolchan E, Robinson M (2001) Behavioral and neural consequences of prenatal exposure to nicotine. J Am Acad Child Adolesc Psychiatry 40:630–641
Ettinger U, Joober R, Guzman De, O’Driscoll G (2006) Schizotypy, attention deficit hyperactivity disorder, and dopamine genes. Psychiatry Clin Neurosci 60:764–767
Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P (2005) Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1313–1323
Gizer IR, Ficks C, Waldman ID (2009) Candidate gene studies of ADHD: a meta-analytic review. Hum Genet 126:51–90
Gogos J, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D et al (1998) Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 95:9991–9996
Goor-Lambo G (1987) The reliability of axis V of the multiaxial classification scheme. J Child Psychol Psychiatry 28:597–612
Gothelf D, Michaelovsky E, Frisch A, Zohar AH, Presburger G, Burg M, Aviram-Goldring A, Frydman M et al (2007) Association of the low-active COMT158Met allele with ADHD and OCD in subjects with velocardiofacial syndrome. Int J Neuropsychopharmacol 10(3):301–308
Grace A (2001) Psychostimulant actions on dopamine and limbic system function: relevance to the pathophysiology and treatment of ADHD. In: Solanto MV, Arnsten A, Castellanos F (eds) Stimulant drugs and ADHD: basic and clinical neuroscience. Oxford University Press, Oxford, pp 134–157
Grossman M, Emanuel B, Budarf M (1992) Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1–q11.2. Genomics 12:822–825
Hawi Z, Millar N, Daly G, Fitzgerald M, Gill M (2000) No association between catechol-O-methyltransferase (COMT) gene polymorphism and ADHD in an Irish sample. Am J Med Genet 96:241–243
Hinshaw S (1987) On the distinction between attention problems/hyperactivity and conduct problems/aggression in child psychopathology. Psychol Bull 101:443–463
Keiley M, Howe T, Dodge K, Bates J, Pettit G (2001) The timing of child physical maltreatment: a cross-domain growth analysis of impact on adolescent externalizing and internalizing problems. Dev Psychopathol 13(4):891–912
Kotimaa A, Moilanen I, Taanila A, Ebeling H, Smalley SL, McGough J et al (2003) Maternal smoking and hyperactivity in 8-year-old children. J Am Acad Child Adolesc Psychiatry 42:826–833
Kramer S (1987) Determinants of low birth weight: methodological assessment and meta-analysis. Bull World Health Organ 65:663–737
Kuhne M, Schachar R, Tannock R (1997) Impact of comorbid oppositional or conduct disorder problems on attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 36:1715–1725
Lachman H, Papolos D, Saito T, Yu Y, Szumlanski C, Weinshilboum R (1996) Human catechol-O-methyl transferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmachogenetics 6:243–250
Lammers A, Van Rossum J (1968) Bizarre social behavior in rats induced by a combination of a peripheral decarboxylase inhibitor and DOPA. Eur J Pharmacol 5:103–106
Manor I, Ketter M, Sever Y, Eisenberg J, Cohen H, Ebstein RP, Tyano S (2000) Failure to replicate an association between the catechol-O-methyltransferase polymorphism and attention deficit hyperactivity disorder in a second, independently recruited Israeli cohort. Am J Med Genet (NeuropsychiatricGenetics) 96:858–860
Michaelovsky E, Gothelf D, Korostishevsky M, Frisch A, Burg M, Carmel M et al (2008) Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11.2 DS. Int J Neuropsychopharmacol 11(3):351–363
Milberger S, Biederman J, Faraone S, Jones J (1998) Further evidence of an association between maternal smoking during pregnancy and attention deficit hyperactivity disorder: findings from a high-risk sample of siblings. J Clin Child Psychol 27:352–358
Miller S, Dykes D, Polesky H (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215
Neuman R, Lobos E, Reich W, Henderson C, Sun L-W, Todd R (2007) Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biol Psychiatry 61:1320–1328
Niklasson L, Rasmussen P, Óskarsdóttir S, Gillberg C (2009) Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome. Res Dev Disabil 30(4):763–773
Payton A, Holmes J, Barrett JH, Hever T, Fitzpatrick H, Trumper AL et al (2001) Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study. Am J Med Genet 105:464–470
Polanczyk G, de Lima M, Horta B, Biderman J, Rohde L (2007) The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164:942–948
Poustka F, Burk B, Baestlein M, von Goor-Lambo G, Schermer D (1994) Elterninterview zur Achse V des Multiaxialen Klassifikationsschemas für psychiatrische Erkrankungen im Kindes- und Jugendalter: Assoziierte aktuelle abnorme psychosoziale Umstände (Lifetime-Version). Swets Test, Frankfurt
Qian Q, Wang Y, Zhou R, Li J, Wang B, Glatt S et al (2003) Family-based and case-control association studies of catechol-O-methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism. Am J Med Genet B Neuropsychiatr Genet 118:103–109
Raine A (2002) The role of prefrontal deficits, low autonomic arousal, and early health factors in the development of antisocial and aggressive behavior in children. J Child Psychol Psychiatry 43:417–434
Retz-Junginger P, Retz W, Blocher D, Stieglitz R-D, Georg T, Supprian T et al (2003) Reliabilität und Validität der Wender-Utah-Rating-Scale-Kurzform Retrospektive Erfassung von Symptomen aus dem Spektrum der Aufmerksamkeitsdefizit/Hyperaktivitätsstörung. Nervenarzt 74:987–993
Reuter M, Kirsch P, Henning J (2006) Inferring candiate genes for Attention Deficit Hyperactivity Disorder (ADHD) assessed by the World Health Organization Adult ADHD Self-Report Scale (ASRS). J Neural Transm 113:929–938
Rösler M, Retz W, Retz-Junginger P, Thome J, Supprian T, Nissen T et al (2004) Instrumente zur Diagnostik der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Erwachsenenalter Selbstbeurteilungsskala (ADHS-SB) und Diagnosecheckliste (ADHS-DC). Nervenarzt 75:888–895
Rujescu D, Giegling I, Gietl A, Hartmann A, Möller H (2003) A functional single nucleotide polymorphism (V158M) in the COMT gene is associated with aggressive personality traits. Biol Psychiatry 54:34–39
Rutter M, Silberg J (2002) Gene–environment interplay in relation to emotional and behavioral disturbance. Annu Rev Psychol 53:463–490
Sengupta S, Grizenko N, Schmitz N, Schwartz G, Amor L, Bellingham J et al (2006) COMT Val108/158Met gene variant, birth weight, and conduct disorder in children with ADHD. J Am Acad Child Adolesc Psychiatry 45(11):1363–1369
Sesack SR, Hawrylak VA, Matus C, Guido MA, Levey AI (1998) Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci 18:2697–2708
Stahl S (2000) Essential psychopharmacology. Neuroscientific basis and practical application, 2nd edn. Cambridge University Press, Cambridge
Tahir E, Curran S, Yazgan Y, Ozbay F, Cirakoglu B, Asherson PJ (2000) No association between low and high activity catecholamine-methyl-transferase (COMT) and attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Am J Med Genet 96:285–288
Taylor E, Chadwick O, Heptinstall E, Danckaerts M (1996) Hyperactivity and conduct problems as risk factors for adolescent development. J Am Acad Child Psychiatry 35(9):1213–1226
Thapar A, Langley K, Fowler T, Rice F, Turic D, Whittinger N et al (2005) Catechol-O-methyltransferase gene variant and birth weight predict early-onset antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 62:1275–1278
Thapar A, van den Bree M, Fowler T, Langley K, Whittinger N (2006) Predictors of antisocial behaviour in children with attention deficit hyperactivity disorder. Eur Child Adolesc Psychiatry 15:118–125
Unnewehr S, Schneider S, Margraf J (eds) (1995) Diagnostisches Interview bei psychischen Störungen im Kindes- und Jugendalter (Kinder-DIPS). Springer, Berlin
Volavka J, Bilder R, Nolan K (2004) Catecholamines and aggression: the role of COMT and MAO polymorphisms. Ann NY Acad Sci 1036:393–398
Wiles J, Peters T, Heron J, Gunnell D, Emond A, Lewis G (2005) Fetal growth and childhood behavioral problems: results from the ALSPAC cohort. Am J Epidemiol 163(9):829–837
Willcutt E, Pennington BF, Chabildas NA, Friedman MC, Alexander J (1999) Psychiatric comorbidity associated with DSM-IV ADHD in a nonreferred sample of twins. J Am Acad Child Adolesc Psychiatry 38:1355–1362
Acknowledgments
We thank the children and their families for their participation in the study and Ulrike Schülter for expert technical assistance. Bernd Janthur, MD, Child Psychiatrist, Dillingen, Germany closely cooperated with this project. This research was supported by the German Research Organisation (Deutsche Forschungsgemeinschaft, DFG) by grants ME 1923/5-1, ME 1923/5-3, and GRK 1389/1.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pálmason, H., Moser, D., Sigmund, J. et al. Attention-deficit/hyperactivity disorder phenotype is influenced by a functional catechol-O-methyltransferase variant. J Neural Transm 117, 259–267 (2010). https://doi.org/10.1007/s00702-009-0338-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-009-0338-2